Sirnaomics announces interim data from phase-II clinical trial of STP705 to treat cutaneous BCC
The interim data, which examines results from three cohorts with 15 total subjects, shows a dose response with complete response,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.